Combination of immune checkpoint inhibitors and tyrosine kinase inhibitors for the treatment of renal cell carcinoma

Stuhler, Viktoria; Rausch, Steffen; Maas, Jan Moritz; Stenzl, Arnulf; Bedke, Jens

dc.contributor.author	Stühler, Viktoria
dc.contributor.author	Rausch, Steffen
dc.contributor.author	Maas, Moritz
dc.contributor.author	Stenzl, Arnulf
dc.contributor.author	Bedke, Jens
dc.date.accessioned	2022-08-02T08:22:07Z
dc.date.available	2022-08-02T08:22:07Z
dc.date.issued	2021
dc.identifier.issn	1471-2598
dc.identifier.uri	http://hdl.handle.net/10900/129844
dc.language.iso	en	en
dc.publisher	Abingdon	de_DE
dc.relation.uri	http://dx.doi.org/10.1080/14712598.2021.1890713
dc.subject.ddc	570	de_DE
dc.subject.ddc	610	de_DE
dc.title	Combination of immune checkpoint inhibitors and tyrosine kinase inhibitors for the treatment of renal cell carcinoma	de_DE
dc.type	Article	de_DE
utue.quellen.id	20220404000000_02495
utue.publikation.seiten	1215-1226	de_DE
utue.personen.roh	Stuhler, Viktoria
utue.personen.roh	Rausch, Steffen
utue.personen.roh	Maas, Jan Moritz
utue.personen.roh	Stenzl, Arnulf
utue.personen.roh	Bedke, Jens
dcterms.isPartOf.ZSTitelID	Expert Opinion on Biological Therapy	de_DE
dcterms.isPartOf.ZS-Issue	9	de_DE
dcterms.isPartOf.ZS-Volume	21	de_DE
utue.fakultaet	04 Medizinische Fakultät